Medicus Pharma (NASDAQ:MDCX) Trading Down 4.4% – What’s Next?

Medicus Pharma Ltd. (NASDAQ:MDCX) shares were down 4.4% on Friday . The stock traded as low as $3.16 and last traded at $3.29. Approximately 27,849 shares were traded during mid-day trading, a decline of 49% from the average daily volume of 54,424 shares. The stock had previously closed at $3.44.

Analysts Set New Price Targets

MDCX has been the topic of a number of research reports. Maxim Group assumed coverage on shares of Medicus Pharma in a report on Tuesday, December 17th. They issued a “buy” rating and a $10.00 target price on the stock. Brookline Capital Management raised shares of Medicus Pharma to a “strong-buy” rating in a research note on Monday, December 23rd.

Medicus Pharma Price Performance

The company’s fifty day moving average price is $3.13.

Institutional Investors Weigh In On Medicus Pharma

A hedge fund recently bought a new stake in Medicus Pharma stock. Interchange Capital Partners LLC acquired a new position in Medicus Pharma Ltd. (NASDAQ:MDCX) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund acquired 1,457,165 shares of the company’s stock, valued at approximately $3,628,000. Medicus Pharma comprises about 1.3% of Interchange Capital Partners LLC’s holdings, making the stock its 15th largest holding. Interchange Capital Partners LLC owned approximately 13.43% of Medicus Pharma as of its most recent SEC filing.

About Medicus Pharma

Medicus Pharma Ltd is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutics assets. Medicus Pharma Ltd is based in Toronto, Ontario.